personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
“Welcome to the July issue. Upfront investigates a new approach to making cancer drugs cheaper – with a paper ‘coffee’ filter; and a new report suggesting trust in pharma is nosediving. Tommy Fanning argues that Ireland’s biopharma sector will continue to thrive in light of US tax cuts and Brexit, in “In My View”, while our cover feature examines the future of the Chinese pharmaceutical industry, and what Made in China 2025 might mean for the rest of the world. Our second feature provides hard data, expert insight, and thoughts for the future of biopharma in the first of our three part series on Biopharma Trends. We also Sit Down With Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.